When Dr. Warren Warwick first started working with cystic fibrosis patients in the 1960s, they often would die in childhood.
Today they can live beyond their 50s, and many credit Warwick for his advances in treatment and understanding of the disease.
"Dr. Warwick is one of many individuals, but certainly someone who deserves credit for much of the improvement in increased longevity," said Dr. Antoinette Moran, chief of the pediatric endocrinology and diabetes division at the University of Minnesota Medical School. "Those adults that we have now in their 50s, 60s and 70s [with cystic fibrosis] are certainly getting excellent adult care, but the fact that they are alive now is because of the unusual and it turned out correct approach that Warren Warwick was taking."
Warwick died Feb. 15 in St. Paul. He was 88.
From 1962 to 1999, he led the cystic fibrosis program at the university, retiring from the medical school in 2011. The program gained national attention in 2004 when Dr. Atul Gawande, a surgeon and bestselling author, highlighted it in a New Yorker magazine article as the nation's best for patients with the disease, a genetic disorder that damages the lungs and other organs.
Cystic fibrosis patient "longevity here at the University of Minnesota has consistently been at least a decade longer than anyone else in the world," Moran said.
Warwick developed a compression vest that cystic fibrosis patients use to clear mucus from their lungs, helping them stay healthy and giving them the ability to live independently. "He partnered with industry at a time when few people were doing that to really come up with the best product and now every CF patient in the developed world has a vest," Moran said.
It was just one of many advancements that he pioneered. "He was just constantly pushing to know more and learn more so he could extend the lives of his patients," she said. "He was a visionary leader."